Gene · 406901
Papers3,765
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 3,765
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Silencing of long noncoding RNA X-inactive specific transcript alleviates Aβ1-42-induced microglia-mediated neurotoxicity by shifting microglial M1/M2 polarization. | Int J Immunopathol Pharmacol | 2023 | 37400958 | PubTator, text mining | PubMed |
| Common molecular signatures between coronavirus infection and Alzheimer's disease reveal targets for drug development. | bioRxiv | 2023 | 37398415 | PubTator, text mining | PubMed |
| The lncRNA RMST is drastically downregulated in anaplastic thyroid carcinomas where exerts a tumor suppressor activity impairing epithelial-mesenchymal transition and stemness. | Cell Death Discov | 2023 | 37393309 | PubTator, text mining | PubMed |
| Identification of prognosis value and immune microenvironment features of ceRNAs in NSCLC with distinct gene mutation. | Aging (Albany NY) | 2023 | 37390335 | PubTator, text mining | PubMed |
| Roles of circRNA dysregulation in esophageal squamous cell carcinoma tumor microenvironment. | Front Oncol | 2023 | 37384299 | PubTator, text mining | PubMed |
| Angiogenesis and Hepatocellular Carcinoma: From Molecular Mechanisms to Systemic Therapies. | Medicina (Kaunas) | 2023 | 37374319 | PubTator, text mining | PubMed |
| The Link between Diabetes, Pancreatic Tumors, and miRNAs-New Players for Diagnosis and Therapy? | Int J Mol Sci | 2023 | 37373398 | PubTator, text mining | PubMed |
| Can Dietary Actives Affect miRNAs and Alter the Course or Prevent Colorectal Cancer? | Int J Mol Sci | 2023 | 37373289 | PubTator, text mining | PubMed |
| Comprehensive Analysis of Circular RNAs in Endothelial Cells. | Int J Mol Sci | 2023 | 37373172 | PubTator, text mining | PubMed |
| MicroRNAs as Potential Biomarkers in Gynecological Cancers. | Biomedicines | 2023 | 37371799 | PubTator, text mining | PubMed |
| Insight into the Inter-Organ Crosstalk and Prognostic Role of Liver-Derived MicroRNAs in Metabolic Disease Progression. | Biomedicines | 2023 | 37371692 | PubTator, text mining | PubMed |
| Identification of m7G-Related miRNA Signatures Associated with Prognosis, Oxidative Stress, and Immune Landscape in Lung Adenocarcinoma. | Biomedicines | 2023 | 37371664 | PubTator, text mining | PubMed |
| Obesity, non-alcoholic fatty liver disease and hepatocellular carcinoma: current status and therapeutic targets. | Front Endocrinol (Lausanne) | 2023 | 37361533 | PubTator, text mining | PubMed |
| Roles and implications of mRNA N6 -methyladenosine in cancer. | Cancer Commun (Lond) | 2023 | 37350762 | PubTator, text mining | PubMed |
| Circulating and Endometrial Tissue microRNA Markers Associated with Endometrial Cancer Diagnosis, Prognosis, and Response to Treatment. | Cancers (Basel) | 2023 | 37345024 | PubTator, text mining | PubMed |
| A Review of micro RNAs changes in T2DM in animals and humans. | J Diabetes | 2023 | 37329278 | PubTator, text mining | PubMed |
| LncRNA LINC01569 promotes M2 macrophage polarization to accelerate hypopharyngeal carcinoma progression through the miR-193a-5p/FADS1 signaling axis. | J Cancer | 2023 | 37325064 | PubTator, text mining | PubMed |
| Abnormal expression of long non-coding RNA FGD5-AS1 affects the development of ovarian cancer through regulating miR-107/RBBP6 axis. | Chin J Physiol | 2023 | 37322627 | PubTator, text mining | PubMed |
| Emerging roles of the long non-coding RNA NEAT1 in gynecologic cancers. | J Cell Commun Signal | 2023 | 37310654 | PubTator, text mining | PubMed |
| MiR-107 Activates NF- κ B versus A β Analysis of the regulatory effect of 1-42 induced apoptosis in Alzheimer's disease cells. | Cell Mol Biol (Noisy-le-grand) | 2023 | 37300691 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406901/papers?page=17